A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial)

Cağdaş Unlü, Niels de Korte, Lidewine Daniels, Esther C J Consten, Miguel A Cuesta, Michael F Gerhards, Anna A W van Geloven, Edwin S van der Zaag, Joost A B van der Hoeven, Rutger Klicks, Huib A Cense, Rudi M H Roumen, Quirijn A J Eijsbouts, Johan F Lange, Paul Fockens, Corianne A J M de Borgie, Wilem A Bemelman, Johannes B Reitsma, Hein B A C Stockmann, Bart C Vrouenraets, Marja A Boermeester, Dutch Diverticular Disease 3D Collaborative Study Group, Cağdaş Unlü, Niels de Korte, Lidewine Daniels, Esther C J Consten, Miguel A Cuesta, Michael F Gerhards, Anna A W van Geloven, Edwin S van der Zaag, Joost A B van der Hoeven, Rutger Klicks, Huib A Cense, Rudi M H Roumen, Quirijn A J Eijsbouts, Johan F Lange, Paul Fockens, Corianne A J M de Borgie, Wilem A Bemelman, Johannes B Reitsma, Hein B A C Stockmann, Bart C Vrouenraets, Marja A Boermeester, Dutch Diverticular Disease 3D Collaborative Study Group

Abstract

Background: Conservative treatment of uncomplicated or mild diverticulitis usually includes antibiotic therapy. It is, however, uncertain whether patients with acute diverticulitis indeed benefit from antibiotics. In most guidelines issued by professional organizations antibiotics are considered mandatory in the treatment of mild diverticulitis. This advice lacks evidence and is merely based on experts' opinion. Adverse effects of the use of antibiotics are well known, including allergic reactions, development of bacterial resistance to antibiotics and other side-effects.

Methods: A randomized multicenter pragmatic clinical trial comparing two treatment strategies for uncomplicated acute diverticulitis. I) A conservative strategy with antibiotics: hospital admission, supportive measures and at least 48 hours of intravenous antibiotics which subsequently are switched to oral, if tolerated (for a total duration of antibiotic treatment of 10 days). II) A liberal strategy without antibiotics: admission only if needed on clinical grounds, supportive measures only. Patients are eligible for inclusion if they have a diagnosis of acute uncomplicated diverticulitis as demonstrated by radiological imaging. Only patients with stages 1a and 1b according to Hinchey's classification or "mild" diverticulitis according to the Ambrosetti criteria are included. The primary endpoint is time-to-full recovery within a 6-month follow-up period. Full recovery is defined as being discharged from the hospital, with a return to pre-illness activities, and VAS score below 4 without the use of daily pain medication. Secondary endpoints are proportion of patients who develop complicated diverticulitis requiring surgery or non-surgical intervention, morbidity, costs, health-related quality of life, readmission rate and acute diverticulitis recurrence rate. In a non-inferiority design 264 patients are needed in each study arm to detect a difference in time-to-full recovery of 5 days or more with a power of 85% and a confidence level of 95%. With an estimated one percent of patients lost to follow up, a total of 533 patients will be included.

Conclusion: A clinically relevant difference of more than 5 days in time-to-full recovery between the two treatment strategies is not expected. The liberal strategy without antibiotics and without the strict requirement for hospital admission is anticipated to be more a more cost-effective approach.

Trial registration number: NCT01111253.

Figures

Figure 1
Figure 1
Study flow chart.

References

    1. Parks TG. Natural history of diverticular disease of the colon: a review of 521 cases. BMJ. 1969;4:639–642. doi: 10.1136/bmj.4.5684.639.
    1. Mendeloff AI. Thoughts on epidemiology of diverticular disease. Clin Gastroenterel. 1986;15:855–77.
    1. Sarin S, Boulos PB. Long-term outcome of patients presenting with acute complications of diverticular disease. Ann R Coll Surg Engl. 1994;76:117–120.
    1. Painter NS, Burkitt DP. Diverticular disease of the colon:a deficiency disease of Western civilization. Br Med J. 1971;2:450–454. doi: 10.1136/bmj.2.5759.450.
    1. Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Trichopoulos DV, Willett WC. A prospective study of alcohol, smoking, caffeine, and the risk of symptomatic diverticular disease in men. Ann Epidemiol. 1995;5:221–228. doi: 10.1016/1047-2797(94)00109-7.
    1. Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Willett WC. Use of acetaminophen and nonsteroidal anti-inflammatory drugs: a prospective study and the risk of symptomatic diverticular disease in men. Arch Fam Med. 1998;7:255–260. doi: 10.1001/archfami.7.3.255.
    1. Tursi A, Brandimarte G, Elisei W, Giorgetti GM, Inchingolo CD, Aiello F. Faecal calprotectin in colonic diverticular disease; a case-control study. Int J Colorectal Dis. 2009;24:49–55. doi: 10.1007/s00384-008-0595-9.
    1. Mueller MH, Glatzle J, Kasparek MS, Becker HD, Jehle EC, Zittel TT, Kreis ME. Long-term outcome of conservative treatment in patients with diverticulitis of the sigmoid colon. Eur J Gastroenterol Hep. 2005;17:649–654. doi: 10.1097/00042737-200506000-00009.
    1. Lameris W, van Randen A, Bipat S, Bossuyt PM, Boermeester MA, Stoker J. Meta-analysis of accuracy of CT and US in diverticulitis. Eur Radiol. 2008;18(11):2498–511. doi: 10.1007/s00330-008-1018-6.
    1. Kaiser AM, Jiang JK, Lake JP, Ault G, Artinyan A, Gonzalez-Ruiz C, Essani R, Beart RW Jr. The managment of complicated diverticulitis and the role of computed tomography. Am J Gastroenter. 2005;100:910–917. doi: 10.1111/j.1572-0241.2005.41154.x.
    1. Wasvary H, Turfah F, Kadro O, Beauregard W. Same hospitalization resection for acute diverticulitis. Am Surg 199. pp. 632–5.
    1. Ambrosetti P, Grossholz M, Becker C, Terrier F, Morel P. Computed tomography in acute left colonic diverticulitis. Br J Surg. 1997;84:532–534. doi: 10.1002/bjs.1800840427.
    1. Shaikh S, Krukowski ZH. Outcome of a conservative policy for managing acute sigmoid diverticulitis. Br J Surg. 2007;94:876–9. doi: 10.1002/bjs.5703.
    1. Hjern F, Josephson T, Altman D, Holmström B, Johansson C. Outcome of younger patients with acute diverticulitis. Br J Surg. 2008;95:758–764. doi: 10.1002/bjs.6137.
    1. Jacobs DO. Diverticulitis. N Engl J Med. 2007;357:2057–66. doi: 10.1056/NEJMcp073228.
    1. Brook I, Farzier EH. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. Clinical Microbiology. 2000;49:827–830.
    1. Kellum JM, Sugerman HJ, Coppa GF, Way LR, Fine R, Herz B, Speck EL, Jackson D, Duma RJ. Randomized, prospective comparison of cefoxitin and gentamicin-clindamycin in the treatment of acute colonic diverticulitis. Clin Ther. 1992;14(3):376–384.
    1. Fink M, Smith LE, Rosenthal D. Antibiotic choice in the nonoperative management of acute divertiulitis coli. Am Surg. 1981;47(5):201–203.
    1. Ridgway P, Latif A, Shabbir J, Ofriokuma F, Hurley MJ, Evoy D, O'Mahony JB, Mealy K. Randomised Controlled Trial of Oral versus Intravenous Therapy for Clinically Diagnosed Acute Uncomplicated Diverticulitis. Colorectal Dis. 2009;11(9):941–6. doi: 10.1111/j.1463-1318.2008.01737.x.
    1. Hjern F, Josephson T, Altman D, Holmström B, Mellgren A, Pollack J, Johansson C. Conservative treatment of acute colonic diverticulitis: are antibiotics always mandatory? Scan J Gastro. 2007;42:41–4. doi: 10.1080/00365520600780650.
    1. Van de Linde MJ, Wikkeling M, Driessen WM, Croiset van Uchelen FA, Roumen RM. Is er een rol voor antibiotica bij de conservatieve behandeling van acute diverticulitis coli? Ned Tijdschr Heelk. 1996;5:194–7.
    1. Munikrishnan V, Helmy A, Elkhider H, Omer AA. Management of acute diverticulitis in the East Anglian region: results of a United Kingdom regional survey. Dis Colon Rectum. 2006;49(9):1332–40. doi: 10.1007/s10350-006-0594-2.
    1. Stollman NH, Raskin JB. Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practise Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999;94(11):3110–21. doi: 10.1111/j.1572-0241.1999.01501.x.
    1. Rafferty J, Shellito P, Hyman NH, Buie WD. Standard committee of American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 2006;49(7):939–44. doi: 10.1007/s10350-006-0578-2.
    1. Kohler L, Sauerland S, Neugebauer E. Diagnosis and treatment of diverticular disease: Results of a consensus development conference. The scientific committee of the European association for endoscopic surgery. Surg Endosc. 1999;13(4):430–6. doi: 10.1007/s004649901007.
    1. Surgical treatment of diverticulitis. Patient care committee of the Society of Surgery of the Alimentary Tract (SSAT) J Gastrointest Surg. 1999;3(2):212–3. doi: 10.1016/S1091-255X(99)80037-7.
    1. World Gastroenterology Organisation.
    1. Stichting Werkgroep AntibioticaBeleid.
    1. Johannes CB, Ziyadeh N, Seeger JD, Tucker E, Reiter C, Faich G. Incidence of allergic reactions associated with antibacterial use in a large, managed care organization. Drug Safety. 2007;30(8):705–713. doi: 10.2165/00002018-200730080-00007.
    1. Guideline Summary.
    1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 2009;136(5 Suppl):e28.
    1. Loffeld RJ, van der Putten AB. Diverticular disease of the colon and concomitant abnormalities in patients undergoing endoscopic evaluation of the large bowel. Colorectal Dis. 2002;4(3):189–192. doi: 10.1046/j.1463-1318.2002.00328.x.
    1. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–11. doi: 10.1053/gast.2002.32978.
    1. Etzioni DA, Mack TM, Beart RW, Kaiser AM Jr. Diverticulitis in the United States: 1998-2005 Changing Patterns of Disease and Treatment. Ann Surg. 2009;249(2):210–217. doi: 10.1097/SLA.0b013e3181952888.
    1. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, Varonen H, Rautakorpi UM, Williams JW Jr, Mäkelä M. Antibiotics for acute maxillary sinusitis. Cochrane Database of Systematic Reviews. 2008;2:CD000243.
    1. Vouloumanou EK, Karageorgopoulos DE, Kazantzi MS, Kapaskelis AM, Falagas ME. Antibiotics versus placebo or waithfull watching for acute otitis media: A meta-analysis of randomised controlled trials. J Antimicrob Chemother. 2009;64:116–24. doi: 10.1093/jac/dkp166.
    1. Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect. 2009;15(Suppl 3):12–15. doi: 10.1111/j.1469-0691.2009.02725.x.
    1. Nelson R. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database of Systematic Reviews. 2007;3:CD004610.
    1. Di Mario F, Aragona G, Leandro G, Comparato G, Fanigliulo L, Cavallaro LG, Cavestro GM, Iori V, Maino M, Moussa AM, Gnocchi A, Mazzocchi G, Franzé A. Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci. 2005;50(3):581–6. doi: 10.1007/s10620-005-2478-z.
    1. Latella G, Pimpo MT, Sottili S, Zippi M, Viscido A, Chiaramonte M, Frieri G. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis. 2003;18(1):55–62. doi: 10.1007/s00384-002-0396-5.
    1. Tursi A, Brandimarte G, Daffina R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis. 2002;34(7):510–5. doi: 10.1016/S1590-8658(02)80110-4.
    1. Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon. Dig Dis Sci. 2007;52(3):671–4. doi: 10.1007/s10620-006-9551-0.
    1. Mizuki A, Nagata H, Tatemichi M, Kaneda S, Tsukada N, Ishii H, Hibi T. The out-patient management of patients with acute mild-to-moderate colonic diverticulitis. Aliment Pharmacol Ther. 2005;21(7):889–97. doi: 10.1111/j.1365-2036.2005.02422.x.
    1. Sugihara K, Muto T, Morioko Y, Asano A, Yamamoto T. Diverticular disease of the colon in Japan. A review of 615 cases. Dis Colon Rectum. 1984;27(8):531–7. doi: 10.1007/BF02555517.
    1. Strate LL. Lower GI bleeding: epidemiology and diagnosis. Gastroenterology Clinics of North America. 2005;34(4):643–664. doi: 10.1016/j.gtc.2005.08.007.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel